Barclays PLC 13D and 13G filings for Fulgent Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-21 4:52 pm Unchanged |
2024-12-31 | 13G | Fulgent Genetics, Inc. FLGT |
Barclays PLC | 1,658,059 5.420% |
0 (Unchanged) |
Filing |
| 2025-02-07 4:34 pm Purchase |
2024-12-31 | 13G | Fulgent Genetics, Inc. FLGT |
Barclays PLC | 1,658,059 5.420% |
1,658,059 (New Position) |
Filing |